United States Thyroid Cancer Drug Market Report 2016

November 2016 | 102 pages | ID: UC65D2DD557EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Thyroid Cancer Drug

Revenue, means the sales value of Thyroid Cancer Drug

This report studies sales (consumption) of Thyroid Cancer Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abott Laboratories
• Genzyme
• Eisai
• Pfizer
• Lannett
• Mylan
• Actavis
• RLC Labs
• Akrimax

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Thyroid Cancer Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Thyroid Cancer Drug Market Report 2016

1 THYROID CANCER DRUG OVERVIEW

1.1 Product Overview and Scope of Thyroid Cancer Drug
1.2 Classification of Thyroid Cancer Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Thyroid Cancer Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Thyroid Cancer Drug (2011-2021)
  1.4.1 United States Thyroid Cancer Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Thyroid Cancer Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES THYROID CANCER DRUG COMPETITION BY MANUFACTURERS

2.1 United States Thyroid Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Thyroid Cancer Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Thyroid Cancer Drug Average Price by Manufactures (2015 and 2016)
2.4 Thyroid Cancer Drug Market Competitive Situation and Trends
  2.4.1 Thyroid Cancer Drug Market Concentration Rate
  2.4.2 Thyroid Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES THYROID CANCER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Thyroid Cancer Drug Sales and Market Share by Type (2011-2016)
3.2 United States Thyroid Cancer Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Thyroid Cancer Drug Price by Type (2011-2016)
3.4 United States Thyroid Cancer Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES THYROID CANCER DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Thyroid Cancer Drug Sales and Market Share by Application (2011-2016)
4.2 United States Thyroid Cancer Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES THYROID CANCER DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Abott Laboratories
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abott Laboratories Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Genzyme
  5.2.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Genzyme Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Eisai
  5.3.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eisai Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Pfizer
  5.4.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Pfizer Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Lannett
  5.5.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Lannett Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Mylan
  5.6.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Mylan Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Actavis
  5.7.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Actavis Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 RLC Labs
  5.8.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 RLC Labs Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Akrimax
  5.9.2 Thyroid Cancer Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Akrimax Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 THYROID CANCER DRUG MANUFACTURING COST ANALYSIS

6.1 Thyroid Cancer Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Thyroid Cancer Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Thyroid Cancer Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Thyroid Cancer Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES THYROID CANCER DRUG MARKET FORECAST (2016-2021)

10.1 United States Thyroid Cancer Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Thyroid Cancer Drug Sales Forecast by Type (2016-2021)
10.3 United States Thyroid Cancer Drug Sales Forecast by Application (2016-2021)
10.4 Thyroid Cancer Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Thyroid Cancer Drug
Table Classification of Thyroid Cancer Drug
Figure United States Sales Market Share of Thyroid Cancer Drug by Type in 2015
Table Application of Thyroid Cancer Drug
Figure United States Sales Market Share of Thyroid Cancer Drug by Application in 2015
Figure United States Thyroid Cancer Drug Sales and Growth Rate (2011-2021)
Figure United States Thyroid Cancer Drug Revenue and Growth Rate (2011-2021)
Table United States Thyroid Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Thyroid Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thyroid Cancer Drug Sales Share by Manufacturers
Figure 2016 Thyroid Cancer Drug Sales Share by Manufacturers
Table United States Thyroid Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table United States Thyroid Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Thyroid Cancer Drug Revenue Share by Manufacturers
Table 2016 United States Thyroid Cancer Drug Revenue Share by Manufacturers
Table United States Market Thyroid Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Thyroid Cancer Drug Average Price of Key Manufacturers in 2015
Figure Thyroid Cancer Drug Market Share of Top 3 Manufacturers
Figure Thyroid Cancer Drug Market Share of Top 5 Manufacturers
Table United States Thyroid Cancer Drug Sales by Type (2011-2016)
Table United States Thyroid Cancer Drug Sales Share by Type (2011-2016)
Figure United States Thyroid Cancer Drug Sales Market Share by Type in 2015
Table United States Thyroid Cancer Drug Revenue and Market Share by Type (2011-2016)
Table United States Thyroid Cancer Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Thyroid Cancer Drug by Type (2011-2016)
Table United States Thyroid Cancer Drug Price by Type (2011-2016)
Figure United States Thyroid Cancer Drug Sales Growth Rate by Type (2011-2016)
Table United States Thyroid Cancer Drug Sales by Application (2011-2016)
Table United States Thyroid Cancer Drug Sales Market Share by Application (2011-2016)
Figure United States Thyroid Cancer Drug Sales Market Share by Application in 2015
Table United States Thyroid Cancer Drug Sales Growth Rate by Application (2011-2016)
Figure United States Thyroid Cancer Drug Sales Growth Rate by Application (2011-2016)
Table Abott Laboratories Basic Information List
Table Abott Laboratories Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abott Laboratories Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Genzyme Basic Information List
Table Genzyme Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genzyme Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Lannett Basic Information List
Table Lannett Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lannett Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actavis Thyroid Cancer Drug Sales Market Share (2011-2016)
Table RLC Labs Basic Information List
Table RLC Labs Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table RLC Labs Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Akrimax Basic Information List
Table Akrimax Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akrimax Thyroid Cancer Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thyroid Cancer Drug
Figure Manufacturing Process Analysis of Thyroid Cancer Drug
Figure Thyroid Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Thyroid Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Thyroid Cancer Drug
Table Distributors/Traders List
Figure United States Thyroid Cancer Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Thyroid Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Thyroid Cancer Drug Production Forecast by Type (2016-2021)
Table United States Thyroid Cancer Drug Consumption Forecast by Application (2016-2021)